Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
+4.2M
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
+$218M
-
Put/Call ratio
-
1.44
-
Number of buys
-
89
-
Number of sells
-
-27
-
Price
-
$51.77
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2014
137 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 79.5M outstanding shares and own 34.15% of the company stock.
Largest 10 shareholders include FMR LLC (5.04M shares), WELLINGTON MANAGEMENT GROUP LLP (2.33M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2.08M shares), BB Biotech AG (1.23M shares), VANGUARD GROUP INC (1.18M shares), Sectoral Asset Management Inc (1.14M shares), BlackRock Fund Advisors (1.09M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (869K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (731K shares), and State Street Corp (696K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.